#USA #biopharmaceuticals #Millrock Technology #Kingston, NY #Tom Hochuli

Leadership Transition at Millrock Technology

Millrock Technology Inc. has announced the appointment of Tom Hochuli as its new Chief Executive Officer (CEO) effective immediately. This strategic decision, disclosed on January 27, 2026, is geared toward reinforcing Millrock's position as an innovator of freeze-drying and lyophilization solutions primarily serving the life sciences and biopharmaceutical sectors.

Who is Tom Hochuli?

Tom Hochuli arrives at Millrock with a robust background, boasting over thirty years of executive experience across various facets of the life sciences industry, particularly in medical devices and biologics manufacturing. His career reflects a commitment to operational excellence and a drive to enhance organizational performance. Prior to this role, Hochuli served as President of a biologics-centric company that provided comprehensive services to biotechnology and biopharmaceutical clients. During his tenure, he spearheaded a significant operational and strategic transformation that markedly improved the organization's financial health and streamlined workflows for sustainability.

In addition to his previous role, Hochuli’s career has seen him manage mid-sized life sciences companies, scaling operations while preparing them for successful exits—underscoring his expertise in navigating the complex landscapes of manufacturing and strategic planning.

Vision for Millrock

With his proven track record in operational leadership, Hochuli is anticipated to play a crucial role in advancing Millrock's vision. In his inaugural statement, he expressed enthusiasm for Millrock's distinguished engineering capabilities and commitment to quality. "Millrock is a highly differentiated business with strong engineering capabilities, deep application expertise, and a reputation for quality that truly matters to its customers," Hochuli stated.

His vision is to further deepen the company's technological advancements while investing in its workforce and operational capabilities. By doing so, he aims to bolster support for clients in bringing critical therapies to market, thereby improving patient outcomes across the healthcare spectrum.

The Future of Millrock Technology

Bill Pezza, Executive Chairman for Millrock, emphasized Hochuli's fit within the company, commenting, "Tom is a proven company builder with a deep understanding of complex manufacturing operations, team development, and the life sciences end market. His leadership will be pivotal as we move into the next chapter of Millrock's journey."

Millrock Technology is renowned for its cutting-edge freeze-drying and lyophilization processes, which are vital for maintaining the quality and efficacy of pharmaceutical products. As the company continues to enhance its capabilities under Hochuli's leadership, there is cautious optimism about its growth trajectory and sustained impact within the biopharmaceutical sector.

About Millrock Technology

Founded with the aim of innovating in the freeze-drying landscape, Millrock Technology specializes in designing and developing both laboratory and production-scale lyophilizers, as well as advanced process control technologies aimed at improving efficiency and compliance. As it embarks on this new chapter under Tom Hochuli's leadership, stakeholders and clients alike watch with interest to see how these changes will unfold.

For more information about Millrock Technology, visit their official website at Millrock Technology.